BNP Paribas downgrades Talanx stock to Neutral from Outperform
Published on 10/01/2026 at 11:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Talanx (ISIN DE000TLX1005) was trading at EUR 115.65 at Lang & Schwarz on October 1, 2026 at 10:44 a.m. CEST, down 0.81 percent from the prior close of EUR 116.60. The latest analyst signal came on September 22, 2026, when Fintel reported that BNP Paribas cut its view from Outperform to Neutral.
BNP Paribas turns more cautious
The downgrade followed a strong advance in Talanx stock, according to Fintel. The same report put the consensus target at EUR 137.26 as of September 14, 2026, with a median of EUR 134.64 and 13 recommendations in the September 1, 2026 period.
Against the Lang & Schwarz price of EUR 115.65, the consensus target of EUR 137.26 represents 18.70 percent upside. That comparison shows why the neutral rating and the broader analyst view point in different directions.
Record half-year supports guidance
For the first half of 2026, Talanx generated net income of EUR 1.5 billion, an increase of 9.00 percent from the prior-year period, according to EuropeSays on September 24, 2026. Return on equity reached 21.50 percent, while the solvency ratio stood at 246.00 percent.
The company raised its full-year 2026 net income outlook to significantly above EUR 2.7 billion, with return on equity expected to be slightly above 19.00 percent, EuropeSays reported. Retail International net income increased 16.00 percent to EUR 387.0 million in the first half, helping offset a 1.00 percent decline in Retail Germany insurance revenue.
Targets span EUR 120 to EUR 163
The analyst picture remains unusually wide. Investing.com listed Berenberg at Buy with a EUR 163.00 target dated August 18, 2026, while BNP Paribas was listed at Neutral with a EUR 120.00 target dated September 8, 2026.
The gap between those targets is EUR 43.00, or 35.83 percent of the lower target. For investors, the central question is whether the record first-half earnings can offset concerns about softer insurance pricing and higher claims volatility in the second half.
Next report arrives November 12
Talanx lists November 12, 2026, as the date for results covering the period ended September 30, 2026, on its Talanx investor-relations page. The report will test whether the first-half trajectory and the raised full-year outlook remain intact after the traditionally more loss-sensitive third quarter.
Market capitalization was EUR 29.9 billion on October 1, 2026, and the 52-week range was EUR 97.65 to EUR 128.80. The further course of trading is shown by the continuously updated real-time quote of Talanx stock.
Talanx stock facts
- Company: Talanx AG
- ISIN: DE000TLX1005
- WKN: TLX100
- Ticker: TLX
- Primary exchange: Xetra
- Price Lang & Schwarz (as of October 1, 2026, 10:44 a.m. CEST): EUR 115.65
- Change versus prior close: minus 0.81 percent
- Prior close Lang & Schwarz (September 30, 2026): EUR 116.60
- Market capitalization: EUR 29.9 billion (as of October 1, 2026)
- 52-week range: EUR 97.65-EUR 128.80 (as of October 1, 2026)
- Sector / Industry: Financial Services / Insurance - Diversified
- Index membership: MDAX
- Next earnings date: November 12, 2026
